Protected: Need to Know: Rapid Fire PET Tumor Board Discussions
There is no excerpt because this is a protected post.
Read MoreSelect Page
Posted by E. David Crawford, MD | Jul 2025
There is no excerpt because this is a protected post.
Read MorePosted by E. David Crawford, MD | Jun 2025
E. David Crawford, MD, presents a case of a 55-year-old prostate cancer survivor with rising PSA five years after radical prostatectomy.
Read MorePosted by E. David Crawford, MD | Apr 2025
There is no excerpt because this is a protected post.
Read MorePosted by E. David Crawford, MD | Apr 2025
There is no excerpt because this is a protected post.
Read MorePosted by Sean P. Collins MD, PhD | Dec 2024
Sean P. Collins, MD, PhD, shares POSLUMA, a new PSMA-specific PET imaging agent approved in May 2023 for prostate cancer.
Read More